PEAK6’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
PEAK6's HCAT Position: Q4 2022 in Review
PEAK6 sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 15,856 shares — an estimated $154K sold.
PEAK6 first reported a position in HCAT in Q1 2021 and held it in 3 quarters. The position peaked at $244K in Q2 2021. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.
- PEAK6 reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
- PEAK6 sold 15,856 Health Catalyst shares in Q4 2022, an estimated $154K.
- PEAK6 first reported a position in Health Catalyst in Q1 2021 and held it in 3 quarters.
- PEAK6's Health Catalyst position peaked at $244K in Q2 2021.
- 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.
Based on PEAK6's 13F filing for Q4 2022, filed 10 Feb 2023.